Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06432010
Other study ID # 2021-A00408-33
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 22, 2021
Est. completion date December 21, 2023

Study information

Verified date May 2024
Source Institut Pasteur de Lille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Researchers have found that the first phase of aging, called "frailty", is insidious, silent and slowly progressive. It begins well before the first signs of aging and possibly before retirement age with physiological reserves that are gradually depleted. Frailty is multifactorial. It is situated between the "robust-vigorous" and "poly-pathological-dependent" stages of aging. This state remains dynamic and above all reversible through screening and awareness of the individual's health determinants as well as motivation to change. The Longevity Pathway was designed to meet several concrete objectives ranging from improving prevention to advancing research on the topic of longevity and aging well. This study aims to evaluate the effect of this personalized support on the quality of life of the consultants, but also on many health parameters, 12 months after the end of the proposed coaching.


Description:

The study will be carried out on healthy volunteers, retired. The main objective of the study is to evaluate the effect of a health check-up followed by a collective "coaching" type of support on the quality of life of retired people 12 months after the end of the coaching sessions.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 21, 2023
Est. primary completion date December 21, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Man or Woman; - Retired; - Having the desire to change his/her lifestyle; - Agreeing to follow the constraints generated by the study (presence during the coaching sessions and the final assessment). - Having signed the informed consent form; - Social insured; Exclusion Criteria: - Presenting a pathology requiring a complementary assessment and/or the implementation of a treatment that could prevent the realization of the coaching or that could modify its effect; - Subject participating in another clinical study or in period of exclusion from another study; - Subject deprived of liberty; - Subject under judicial protection measure; - Whose main investigator or a qualified co-investigator judges that the state of health or the concomitant treatments are not compatible with the good progress of the clinical study;.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Group nutrition and physical activity coaching
Group nutrition and physical activity coaching consists of an initial health check-up, followed by nutrition and physical activity coaching sessions over 7 weeks, 2 telephone follow-ups at 3 and 6 months and finally a final health check-up, 12 months after the end of the group nutrition and physical activity coaching sessions.
Group cognition coaching
Group cognition coaching consists of an initial health check-up, followed by cognition coaching sessions over 7 weeks, 2 telephone follow-ups at 3 and 6 months and finally a final health check-up, 12 months after the end of the cognition coaching sessions.

Locations

Country Name City State
France NutrInvest - Institut Pasteur de Lille Lille Nord

Sponsors (1)

Lead Sponsor Collaborator
Institut Pasteur de Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline on quality of life of retired people 12 months after the end of the coaching sessions. Health quality will be evaluated thanks to a health quality questionnary validated by the World Health Organisation (WHO). 1 year
Secondary Change from baseline on food behaviors at 1 year after the coaching Food behaviors will be measure with Balance and dietary diversity questionnaire proposed by the Institut Pasteur de Lille 1 year
Secondary Change from baseline on food frequency at 1 year after the coaching Food frequency will be measure with 24-hour reminder of ingestas
- Visual analogue scales on changes in eating behavior.
1 year
Secondary Change from baseline on food behavior at 1 year after the coaching Food behaviors will be measure with Visual analogue scales on changes in eating behavior from 10 (yes really a lot) to 0 (not at all) 1 year
Secondary Change from baseline on physical activity behaviors at 1 year after the coaching Visual Analog Scales for Behavioral Change Related to Physical Activity raging from 10 (yes really a lot) to 0 (not at all) 1 year
Secondary Change from baseline on physical activity frequency at 1 year after the coaching Marshall Questionnaire for Physical Activity frequency and two questions to evaluate the sedentarity livestyle level. 1 year
Secondary Change from baseline on endurance at 1 year after the coaching The using test is :
• 6 minutes walk test (endurance) Measured in meters
1 year
Secondary Change from baseline on physical performances (lower limbs) at 1 year after the coaching The using test is :
• Stand up chair test to calculate the number of raise on 30 seconds
1 year
Secondary Change from baseline on physical performances (upper limbs) at 1 year after the coaching The using test is :
•Arm curl test to calculate the number of arm bend
1 year
Secondary Change from baseline on flexibility at 1 year after the coaching The using test is :
•Flexible trunk and posterior chain of lower limbs Measured by index ranging from 5 (the palms of the hands touch the ground) to 1 (the fingertips reach the lower shins)
1 year
Secondary Change from baseline on static balance at 1 year after the coaching The using test is :
Unipodal balance (static balance) Measured in seconds
1 year
Secondary Change from baseline on mobility at 1 year after the coaching The using test is :
Get up and go test Measured by index ranging from 5 (the worst) to 1 (the best)
1 year
Secondary Change from baseline on speed at 1 year after the coaching The using test is :
4 meters walking speed
Measured in seconds
1 year
Secondary Change from baseline on dynamic balance at 1 year after the coaching The using test is :
2 minutes on the spot knee climb This test explores the muscular strength of the lower limbs, dynamic balance and walking Measured in number of knee climb in 2 minutes
1 year
Secondary Change from baseline on cognitive performances at 1 year after the coaching Cognitive performances will be measure with :
- Montreal cognitive assessment test (MOCA test) to evaluate mild cognitive dysfunction
1 year
Secondary Change from baseline on memory at 1 year after the coaching It will be measure with :
- Working Memory Questionnaire
1 year
Secondary Change from baseline on sleep quality at 1 year after the coaching It will be measure with :
- Insomnia Severity Index (ISI) to assess sleep quality
1 year
Secondary Change from baseline on stress management at 1 year after the coaching It will be measure with :
- Cohen's Questionnaire
1 year
Secondary Change from baseline on anxiety at 1 year after the coaching It will be measure with :
- Hospital Anxiety And Depression Queqtionnaire (HAD questionnaire to assess anxiety and depression)
1 year
Secondary Glucose metabolism Blood samples will be collected to analyse fasting blood glucose 1 year
Secondary Lipids metabolism Blood samples will be collected to analyse: total cholesterol, HDL, LDL, TG 1 year
Secondary Anthropometric parameters (Body Masse Index) Weight in kilograms and height in meters will be combined to report BMI in kg/m^2 1 year
Secondary Anthropometric parameters (waist circumference) - Waist circumference in centimeters 1 year
Secondary Body composition Measurement of body fat by DEXA (Dual X Ray Absorptiometry) for half of the total population :
Body fat in grams
Lean mass in grams
Total mass in grams
Visceral fat mass in grams
subcutaneous fat mass in grams
Bone mineral content in grams
1 year
Secondary Body composition Measurement of lean mass by DEXA (Dual X Ray Absorptiometry) for half of the total population :
Body fat in percentage
Lean mass in percentage
Visceral fat mass in percentage
subcutaneous fat mass in percentage
1 year
Secondary Body composition (bone mineral density) Measurement by DEXA (Dual X Ray Absorptiometry) for half of the total population :
- Bone mineral density in grams/cm²
1 year
Secondary Systolic and diastolic blood pressure Systolic and diastolic blood pressure to calculate blood pressure 1 year
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1